| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |